Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Cancer Immunology & Therapy (2024) Volume 7, Issue 1

Harnessing the Potential of Natural Compounds as Metastasis Suppression Agents.

Romin Edwards *

Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, USA

*Corresponding Author:
Romin Edwards
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, USA
E-mail: romin@uab.edu

Received: 02-Feb -2024, Manuscript No. AAJCIT-24-129888; Editor assigned: 03-Feb-2024, PreQC No. AAJCIT-24-129888 (PQ); Reviewed:17-Feb-2024, QC No. AAJCIT-24-129888; Revised:22-Feb-2024, Manuscript No. AAJCIT-24-129888 (R); Published:29-Feb-2024, DOI:10.35841/aara-7.1.194

Citation: Edwards R., Harnessing the potential of natural compounds as metastasis suppression agents. J Cancer Immunol Ther. 2024;7(1):194

Visit for more related articles at Journal of Cancer Immunology & Therapy

Introduction

Metastasis, the spread of cancer cells from the primary tumor to distant organs, remains a formidable challenge in cancer treatment, contributing to the majority of cancer-related deaths. Traditional cancer therapies often target the primary tumor, but metastatic disease requires additional strategies to prevent or inhibit its progression. In recent years, natural compounds derived from plants, herbs, and other sources have garnered attention for their potential to suppress metastasis through various mechanisms. Metastasis is a complex, multistep process involving the dissemination of cancer cells from the primary tumor, intravasation into blood or lymphatic vessels, survival in circulation, extravasation into distant organs, and colonization of secondary sites. This article explores the promising role of natural compounds as metastasis suppression agents and their implications for cancer treatment [1].

Natural compounds, often referred to as phytochemicals, exhibit diverse biological activities and have been studied for their potential anticancer properties. Several natural compounds have demonstrated promising effects on various aspects of the metastatic process, including inhibition of cancer cell migration, invasion, angiogenesis, and epithelial-mesenchymal transition (EMT). These compounds exert their effects through modulation of signaling pathways involved in metastasis, including those mediated by growth factors, cytokines, matrix metalloproteinases (MMPs), and cell adhesion molecules. Each step of the metastatic cascade presents opportunities for intervention, making metastasis a potential target for therapeutic intervention [2].

Natural compounds inhibit the formation of new blood vessels (angiogenesis) required for tumor growth and metastasis by targeting pro-angiogenic factors and signaling pathways involved in vascular endothelial cell proliferation and migration. Natural compounds promote programmed cell death (apoptosis) in cancer cells by activating intrinsic and extrinsic apoptotic pathways, leading to the elimination of metastatic cells. Natural compounds inhibit the transition of cancer cells from epithelial to mesenchymal phenotype, a process associated with increased invasiveness, stemness, and resistance to therapy [3].

Curcumin, a polyphenolic compound found in turmeric, has been shown to inhibit metastasis through its anti-inflammatory, antioxidant, and anti-angiogenic properties. Curcumin suppresses cancer cell migration, invasion, and EMT by modulating signaling pathways such as NF-κB, STAT3, and Wnt/β-catenin [4].

Resveratrol, a polyphenol present in grapes, berries, and red wine, exhibits anti-metastatic effects by inhibiting cancer cell proliferation, migration, and invasion. Resveratrol modulates multiple signaling pathways involved in metastasis, including PI3K/Akt, MAPK, and MMPs [5].

EGCG, a catechin found in green tea, has been shown to inhibit metastasis by suppressing angiogenesis, invasion, and EMT. EGCG modulates multiple signaling pathways, including VEGF, MMPs, and PI3K/Akt/mTOR [6].

Quercetin: Quercetin, a flavonoid abundant in fruits, vegetables, and herbs, exhibits anti-metastatic properties by inhibiting cancer cell migration, invasion, and angiogenesis. Quercetin modulates signaling pathways such as MAPK, PI3K/Akt, and NF-κB [7].

Sulforaphane: Sulforaphane, a phytochemical found in cruciferous vegetables, suppresses metastasis by inhibiting cancer cell migration, invasion, and EMT. Sulforaphane modulates signaling pathways involved in metastasis, including Wnt/β-catenin, NF-κB, and Nrf2 [8].

Natural compounds exert their metastasis suppressive effects through various mechanisms, including: Inhibition of cancer cell migration and invasion: Natural compounds interfere with the ability of cancer cells to migrate and invade surrounding tissues by targeting signaling pathways involved in cytoskeletal dynamics, cell adhesion, and extracellular matrix remodelling [9].

The discovery of natural compounds with metastasis suppressive properties holds promise for the development of novel therapeutic agents for cancer treatment. However, translating preclinical findings into clinical practice requires rigorous evaluation of safety, efficacy, and pharmacokinetics in human studies. Clinical trials investigating the use of natural compounds alone or in combination with conventional therapies for metastatic cancer are underway, providing valuable insights into their potential utility and limitations in clinical settings. Despite the promising preclinical evidence, several challenges remain in harnessing the full potential of natural compounds as metastasis suppression agents. These include issues related to bioavailability, stability, formulation, dose optimization, and off-target effects. Future research efforts should focus on addressing these challenges through innovative drug delivery systems, pharmacological enhancements, and combination therapies targeting multiple steps of the metastatic cascade [10].

conclusion

The impact of lifestyle choices on breast cancer risk underscores the importance of adopting healthy habits and making informed decisions to reduce the likelihood of developing the disease. By prioritizing a balanced diet, regular physical activity, moderation in alcohol consumption, avoidance of smoking, maintenance of a healthy weight, and adherence to recommended screening guidelines, women can empower themselves to take control of their breast health and minimize their risk of breast cancer. Additionally, genetic counseling and testing can provide valuable information for individuals with a family history of breast cancer, enabling them to make proactive choices to mitigate their risk. Through a comprehensive approach encompassing lifestyle modifications, early detection, and personalized risk management, we can work towards reducing the burden of breast cancer and improving outcomes for women worldwide.

References

  1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1-75.

    2. Indexed at, Google Scholar, Cross Ref

  2. Carter LG, D'Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014;21(3):R209-25.

    3. Indexed at,Google Scholar, Cross Ref

  3. Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM, et al. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett. 2007;247(1):115-21.

    4. Indexed at, Google Scholar

  4. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325-37.

    5. Indexed at, Google Scholar, Cross Ref

  5. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinog. 2004;25(1):83-90.

    6. Indexed at, Google Scholar

  6. Miao L, Zhang Y, Huang L. mRNA vaccine for cancer immunotherapy. Mol Cancer. 2021;20(1):1-23.

    7. Indexed at, Google Scholar, Cross Ref

  7. Van Lint S, Renmans D, Broos K, et al., The ReNAissanCe of mRNA-based cancer therapy. Expert Rev Vaccines. 2015;14(2):235-51.

    8. Indexed at, Google Scholar, Cross Ref

  8. Heine A, Juranek S, Brossart P. Clinical and immunological effects of mRNA vaccines in malignant diseases. Mol Cancer. 2021;20(1):1-20.

    9. Indexed at, Google Scholar, Cross Ref

  9. Barbier AJ, Jiang AY, Zhang P, et al., The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol. 2022;40(6):840-54.

    10. Indexed at, Google Scholar, Cross Ref

  10. Beck JD, Reidenbach D, Salomon N, et al., mRNA therapeutics in cancer immunotherapy. Mol Cancer. 2021;20(1):1-24.

    11. Indexed at, Google Scholar,Cross Ref

Get the App